BBIO logo

BridgeBio Pharma (BBIO) Cash from investing

annual CFI:

$60.78M+$6.75M(+12.49%)
December 31, 2024

Summary

  • As of today (May 29, 2025), BBIO annual cash flow from investing activities is $60.78 million, with the most recent change of +$6.75 million (+12.49%) on December 31, 2024.
  • During the last 3 years, BBIO annual CFI has risen by +$261.61 million (+130.27%).
  • BBIO annual CFI is now -86.59% below its all-time high of $453.15 million, reached on December 31, 2022.

Performance

BBIO Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOcash flow metrics

quarterly CFI:

-$1.59M+$1.64M(+50.73%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BBIO quarterly cash flow from investing activities is -$1.59 million, with the most recent change of +$1.64 million (+50.73%) on March 31, 2025.
  • Over the past year, BBIO quarterly CFI has dropped by -$24.35 million (-107.01%).
  • BBIO quarterly CFI is now -101.07% below its all-time high of $149.70 million, reached on June 30, 2022.

Performance

BBIO quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOcash flow metrics

TTM CFI:

$36.43M-$24.35M(-40.06%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BBIO TTM cash flow from investing activities is $36.43 million, with the most recent change of -$24.35 million (-40.06%) on March 31, 2025.
  • Over the past year, BBIO TTM CFI has dropped by -$28.05 million (-43.50%).
  • BBIO TTM CFI is now -92.03% below its all-time high of $456.98 million, reached on September 30, 2022.

Performance

BBIO TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

BBIO Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+12.5%-107.0%-43.5%
3 y3 years+130.3%-101.2%-83.4%
5 y5 years+128.0%-104.2%+120.6%

BBIO Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-86.6%+130.3%-101.1%+50.7%-92.0%at low
5 y5-year-86.6%+128.0%-101.1%+99.4%-92.0%+109.8%
alltimeall time-86.6%+128.0%-101.1%+99.4%-92.0%+109.8%

BBIO Cash from investing History

DateAnnualQuarterlyTTM
Mar 2025
-
-$1.59M(-50.7%)
$36.43M(-40.1%)
Dec 2024
$60.78M(+12.5%)
-$3.24M(-108.5%)
$60.78M(-5.0%)
Sep 2024
-
$38.23M(+1157.8%)
$63.95M(+0.9%)
Jun 2024
-
$3.04M(-86.6%)
$63.41M(-1.7%)
Mar 2024
-
$22.75M(<-9900.0%)
$64.49M(+19.3%)
Dec 2023
$54.03M(-88.1%)
-$66.00K(-100.2%)
$54.03M(-25.0%)
Sep 2023
-
$37.68M(+814.8%)
$72.06M(-60.2%)
Jun 2023
-
$4.12M(-66.5%)
$181.24M(-44.5%)
Mar 2023
-
$12.30M(-31.5%)
$326.82M(-27.9%)
Dec 2022
$453.15M(-325.6%)
$17.96M(-87.8%)
$453.15M(-0.8%)
Sep 2022
-
$146.86M(-1.9%)
$456.98M(+23.8%)
Jun 2022
-
$149.70M(+8.0%)
$369.09M(+67.9%)
Mar 2022
-
$138.62M(+535.9%)
$219.85M(-209.5%)
Dec 2021
-$200.83M
$21.80M(-63.0%)
-$200.83M(+43.8%)
Sep 2021
-
$58.97M(>+9900.0%)
-$139.61M(-42.7%)
DateAnnualQuarterlyTTM
Jun 2021
-
$458.00K(-100.2%)
-$243.63M(-34.7%)
Mar 2021
-
-$282.05M(-439.7%)
-$373.07M(+604.0%)
Dec 2020
-$52.99M(-75.6%)
$83.02M(-284.3%)
-$52.99M(-65.3%)
Sep 2020
-
-$45.05M(-65.1%)
-$152.91M(-49.9%)
Jun 2020
-
-$128.98M(-439.2%)
-$305.20M(+72.6%)
Mar 2020
-
$38.02M(-325.0%)
-$176.80M(-18.6%)
Dec 2019
-$217.25M(+932.8%)
-$16.90M(-91.4%)
-$217.25M(+6.5%)
Sep 2019
-
-$197.34M(>+9900.0%)
-$203.95M(+2727.2%)
Jun 2019
-
-$583.00K(-76.0%)
-$7.21M(-12.9%)
Mar 2019
-
-$2.43M(-32.6%)
-$8.29M(-60.6%)
Dec 2018
-$21.04M(+4433.6%)
-$3.60M(+494.9%)
-$21.04M(+20.6%)
Sep 2018
-
-$605.00K(-63.4%)
-$17.44M(+3.6%)
Jun 2018
-
-$1.66M(-89.1%)
-$16.83M(+10.9%)
Mar 2018
-
-$15.18M
-$15.18M
Dec 2017
-$464.00K
-
-

FAQ

  • What is BridgeBio Pharma annual cash flow from investing activities?
  • What is the all time high annual CFI for BridgeBio Pharma?
  • What is BridgeBio Pharma annual CFI year-on-year change?
  • What is BridgeBio Pharma quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for BridgeBio Pharma?
  • What is BridgeBio Pharma quarterly CFI year-on-year change?
  • What is BridgeBio Pharma TTM cash flow from investing activities?
  • What is the all time high TTM CFI for BridgeBio Pharma?
  • What is BridgeBio Pharma TTM CFI year-on-year change?

What is BridgeBio Pharma annual cash flow from investing activities?

The current annual CFI of BBIO is $60.78M

What is the all time high annual CFI for BridgeBio Pharma?

BridgeBio Pharma all-time high annual cash flow from investing activities is $453.15M

What is BridgeBio Pharma annual CFI year-on-year change?

Over the past year, BBIO annual cash flow from investing activities has changed by +$6.75M (+12.49%)

What is BridgeBio Pharma quarterly cash flow from investing activities?

The current quarterly CFI of BBIO is -$1.59M

What is the all time high quarterly CFI for BridgeBio Pharma?

BridgeBio Pharma all-time high quarterly cash flow from investing activities is $149.70M

What is BridgeBio Pharma quarterly CFI year-on-year change?

Over the past year, BBIO quarterly cash flow from investing activities has changed by -$24.35M (-107.01%)

What is BridgeBio Pharma TTM cash flow from investing activities?

The current TTM CFI of BBIO is $36.43M

What is the all time high TTM CFI for BridgeBio Pharma?

BridgeBio Pharma all-time high TTM cash flow from investing activities is $456.98M

What is BridgeBio Pharma TTM CFI year-on-year change?

Over the past year, BBIO TTM cash flow from investing activities has changed by -$28.05M (-43.50%)
On this page